PTEN (phosphatase and tensin homolog deleted on chromosome
10)
is a tightly regulated dual-specificity phosphatase and key regulator
of the PI3K/AKT/mTOR signaling pathway. PTEN phosphorylation at its
carboxy-terminal tail (CTT) serine/threonine cluster negatively regulates
its tumor suppressor function by inducing a stable, closed, and inactive
conformation. Germline PTEN mutations predispose
individuals to PTEN hamartoma tumor syndrome (PHTS),
a rare inherited cancer syndrome and, intriguingly, one of the most
common causes of autism spectrum disorder (ASD). However, the mechanistic
details that govern phosphorylated CTT catalytic conformational dynamics
in the context of PHTS-associated mutations are unknown. Here, we
utilized a comparative protein structure network (PSN)-based approach
to investigate PTEN CTT phosphorylation-induced conformational dynamics
specific to PTEN-ASD compared to PTEN-cancer phenotypes. Results from
our study show differences in structural flexibility, inter-residue
contacts, and allosteric communication patterns mediated by CTT phosphorylation,
differentiating PTEN-ASD and PTEN-cancer phenotypes. Further, we identified
perturbations among global metapaths and community network connections
within the active site and inter-domain regions, indicating the significance
of these regions in transmitting information across the PSN. Together,
our studies provide a mechanistic underpinning of allosteric regulation
through the coupled interplay of CTT phosphorylation conformational
dynamics in PTEN-ASD and PTEN-cancer mutations. Importantly, the detailed
atomistic interactions and structural consequences of PTEN variants reveal potential allosteric druggable target sites as a
viable and currently unexplored treatment approach for individuals
with different PHTS-associated mutations.